9TH0.F EPSILON HEALTHCARE LTD.

Healthcare Pharmaceuticals Frankfurt Exchange
0.0075 EUR
Close of Nov 11, 2026
0.0045 0.0145
Market cap
EUR 2.92M
P/E
-
P/B
1.14x
ROE
-66.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 9TH0.F undervalued?

Graham number

The Graham number of EPSILON HEALTHCARE LTD. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

EPSILON HEALTHCARE LTD. fundamental analysis

No fundamental analysis for EPSILON HEALTHCARE LTD. yet.

EPSILON HEALTHCARE LTD. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About EPSILON HEALTHCARE LTD.

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulation; and provision …

Full company profile